Mr. Charles Orr is Lead Independent Director of Immunotec Inc. Mr. Orr was an advisor and board member to several private and public companies. Mr. Orr is also the Executive Director of the Direct Selling Education Foundation since March 2009
Lead Independent Director
Age: 67 Director Since 2011
|Orr has 47 years of experience in a variety of industries and distribution channels including financial services, information systems, dietary supplements, food, roses, household products, skincare and water filtration. From 1993 to 2000, Mr. Orr was President and Chief Executive Officer of Shaklee Corporationrationration, which included the brand names of Harry and David, Jackson and Perkins and Shaklee. Prior business associations include RCA, Xerox, Connecticut General, Southwestern Life, Continental Insurance and Federated Investors. Past board affiliations include Herbalife Ltd., Provident Mutual Life Insurance Company, Shaklee Corporationrationration, the Direct Selling Association, the Direct Selling Education Foundation and Zero Technologies LLC.|
The company has return on total asset (ROA) of 4.83 % which means that it generated profit of $4.83 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.35 % meaning that it generated $5.35 on every $100 dollars invested by stockholders.
The company has accumulated 2.05 M in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Immunotec Inc has Current Ratio of 1.39 which is within standard range for the sector.
Entity SummaryImmunotec Inc., a network marketing company, manufactures and sells natural health solutions and dietary supplements in Canada, the United States, Europe, Mexico, and the Caribbean. Immunotec Inc [IMM] is traded on TSX Venture Exchange in Canada. It is located in VaudreuilDorion, QC JV V and employs 13 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| IMM TSXV #B1P77Y5CA
Immunotec Inc has less than 16.16 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Immunotec price boundaries
Promote Immunotec and Charles Orr